SLGL (Sol-Gel Technologies) Moat Score: 6/10 (As of Jun. 26, 2026)


SLGL Sol-Gel Technologies Ltd SLGL
56 GF Score
Price $73.50
GF Value $65.37
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Sol-Gel Technologies Moat Score?

Sol-Gel Technologies SLGL +1.87% 56 Moat Score is 6 as of Jun. 26, 2026. GuruFocus rates SLGL with a GF Score™ of 56/100 and a GF Value™ of $65.37 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 1,404 Biotechnology companies, Sol-Gel Technologies ranks better than 98.93% on this metric.

Sol-Gel Technologies has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Sol-Gel Technologies has Narrow Moat: Sol-Gel Technologies Ltd has a strong narrow moat due to its valuable intellectual property and consistent innovation in dermatological products. The company benefits from some regulatory barriers and customer loyalty, but lacks the scale and network effects for a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Sol-Gel Technologies might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Sol-Gel Technologies  (NAS:SLGL) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Sol-Gel Technologies Moat Score Related Terms

SLGL vs ALEC, LENZ, CNXU: Moat Score Comparison

For the Biotechnology subindustry, Sol-Gel Technologies's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sol-Gel Technologies Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sol-Gel Technologies's Moat Score distribution charts can be found below:

* The bar in red indicates where Sol-Gel Technologies's Moat Score falls into.


SLGL
56GF Score
Sol-Gel Technologies Ltd SLGL
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Sol-Gel Technologies (SLGL) has a Moat Score of 6 as of Jun. 26, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Sol-Gel Technologies ranks #15 out of 1404 companies in the Biotechnology industry, placing it in the top 1.1%.
Is Sol-Gel Technologies' Moat Score too high?
Sol-Gel Technologies' current Moat Score is 6. The Biotechnology industry median Moat Score is 2.00. Sol-Gel Technologies' value of 6 is 200% above this industry median. Based on the distribution chart, Sol-Gel Technologies ranks #15 out of 1404 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sol-Gel Technologies has a GF Score™ of 56/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sol-Gel Technologies' Moat Score compare to ALEC and LENZ?
According to the Biotechnology industry distribution chart, Sol-Gel Technologies ranks #15 out of 1404 companies for Moat Score. This places Sol-Gel Technologies in the top 1% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Sol-Gel Technologies' value of 6 is 200% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,404 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sol-Gel Technologies's current Moat Score of 6 is 200% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sol-Gel Technologies's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sol-Gel Technologies stock overvalued right now?
Based on GuruFocus' analysis, Sol-Gel Technologies (SLGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $65.37, compared to a current price of $73.50 — trading 12.4% above its estimated fair value. The current Moat Score is 6 and 200% above the Biotechnology industry median of 2.00. Sol-Gel Technologies' overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Sol-Gel Technologies (SLGL), the current Moat Score is 6 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sol-Gel Technologies (SLGL) Overvalued in 2026?

Based on GuruFocus' analysis, Sol-Gel Technologies stock appears to be overvalued. The current stock price of $73.50 is trading 12.4% above its estimated GF Value™ of $65.37. GuruFocus considers Sol-Gel Technologies to be Modestly Overvalued.

Key valuation signals for SLGL:

  • Moat Score: 6
  • GF Value™: $65.37 vs. price of $73.50 (12.4% above fair value)
  • GF Score™: 56/100 with 2 warning signs
  • Industry Position: 200% above the Biotechnology median (#15 of 1404)

No single metric tells the full story. See the SLGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sol-Gel Technologies Business Description

Other Exchanges 4SG:Germany
Address 7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
56GF Score

Get the complete analysis for SLGL

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$73.50
Price
$65.37
GF Value